4-diazo-3-methyl-2,5-cyclohexadine-1-one and pharmacetically acceptable
salts thereof
    1.
    发明授权
    4-diazo-3-methyl-2,5-cyclohexadine-1-one and pharmacetically acceptable salts thereof 失效
    4-重氮基-3-甲基-2,5-环己二烯-1-酮及其药物可接受的盐

    公开(公告)号:US4904764A

    公开(公告)日:1990-02-27

    申请号:US808146

    申请日:1985-12-12

    IPC分类号: C07C245/12

    CPC分类号: C07C245/12 Y10S435/933

    摘要: 4-Diazo-3-methoxy-2,5-cyclohexandien-1-one, and pharmaceutically acceptable salts thereof, are antibiotics having antibacterial activity against a variety of gram positive and gram negative bacteria, particularly against anaerobic bacteria. The compound can be prepared by culturing aerobically Penicillium funiculosum A.T.C.C. No. 20783 in a culture medium containing assimilable sources of carbohydrates and nitrogen.

    摘要翻译: 4-重氮基-3-甲氧基-2,5-环己二烯-1-酮及其药学上可接受的盐是对各种革兰氏阳性和革兰氏阴性细菌,特别是对厌氧细菌具有抗菌活性的抗生素。 该化合物可以通过培养有氧青霉菌A.T.C.C. 在含有可同化碳水化合物和氮源的培养基中的第20783号。

    ACE inhibitors produced from Nocardia orientalis
    4.
    发明授权
    ACE inhibitors produced from Nocardia orientalis 失效
    由诺卡氏菌产生的ACE抑制剂

    公开(公告)号:US4474693A

    公开(公告)日:1984-10-02

    申请号:US547151

    申请日:1983-10-31

    IPC分类号: C07K9/00 C07C103/52 C07G7/00

    摘要: N.sup.2 -[N-(N-acetylmuramoyl)-L-alanyl]-N-(5,6-diamino-1-carboxy-6-oxohexyl)-D-.alpha.-glutamine, N.sup.2 -[N-(N-acetylmuramoyl)-L-alanyl]-N-[5,6-diamino-1-[[1-[(1-carboxyethyl)carbamoyl]ethyl]carbamoyl]-6-oxohexyl]-D-.alpha.-glutamine and EM5556C are obtained as a mixture by cultivating a strain of the microorganism Nocardia orientalis A.T.C.C. No. 39444.

    摘要翻译: N 2 - [N-(N-乙酰基氨基甲酰基)-L-丙氨酰] -N-(5,6-二氨基-1-羧基-6-氧代己基)-D-α-谷氨酰胺,N 2 - [N-(N-乙酰基甲酰基 )-L-丙氨酰] -N- [5,6-二氨基-1 - [[1 - [(1-羧基乙基)氨基甲酰基]乙基]氨基甲酰基] -6-氧代己基] -D-α-谷氨酰胺和EM5556C 作为混合物,通过培养微生物诺卡氏菌ATCC菌株 第39444号。